Walter Public Investments Inc. Decreases Stock Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Walter Public Investments Inc. reduced its position in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 31.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,425 shares of the medical instruments supplier’s stock after selling 3,354 shares during the period. Mettler-Toledo International comprises approximately 1.6% of Walter Public Investments Inc.’s portfolio, making the stock its 29th largest position. Walter Public Investments Inc.’s holdings in Mettler-Toledo International were worth $9,086,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the company. State Street Corp lifted its position in shares of Mettler-Toledo International by 1.0% during the 3rd quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier’s stock worth $1,431,693,000 after purchasing an additional 9,009 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Mettler-Toledo International by 0.8% during the 3rd quarter. Geode Capital Management LLC now owns 547,439 shares of the medical instruments supplier’s stock worth $818,906,000 after purchasing an additional 4,166 shares during the last quarter. Principal Financial Group Inc. lifted its position in shares of Mettler-Toledo International by 13.9% during the 4th quarter. Principal Financial Group Inc. now owns 274,563 shares of the medical instruments supplier’s stock worth $335,977,000 after purchasing an additional 33,456 shares during the last quarter. Barclays PLC lifted its position in shares of Mettler-Toledo International by 8.3% during the 3rd quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock worth $384,822,000 after purchasing an additional 19,609 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its position in shares of Mettler-Toledo International by 14.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock worth $332,634,000 after purchasing an additional 28,478 shares during the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Mettler-Toledo International

In other news, insider Christian Magloth sold 790 shares of the business’s stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the transaction, the insider now directly owns 734 shares in the company, valued at $964,248.46. The trade was a 51.84 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Gerry Keller sold 140 shares of the business’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the transaction, the insider now owns 6 shares in the company, valued at approximately $7,524.54. This trade represents a 95.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 1,530 shares of company stock worth $2,024,192 over the last ninety days. 1.94% of the stock is currently owned by company insiders.

Mettler-Toledo International Stock Performance

NYSE MTD opened at $1,290.12 on Thursday. The firm has a market cap of $26.98 billion, a PE ratio of 31.83, a P/E/G ratio of 3.30 and a beta of 1.13. Mettler-Toledo International Inc. has a one year low of $1,142.91 and a one year high of $1,546.93. The firm’s fifty day moving average is $1,289.38 and its two-hundred day moving average is $1,331.49.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, beating analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. Research analysts predict that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current year.

Wall Street Analysts Forecast Growth

MTD has been the topic of several research analyst reports. Wells Fargo & Company lifted their price target on shares of Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the stock an “equal weight” rating in a research note on Monday, February 10th. Stifel Nicolaus cut their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research note on Monday, November 11th. Citigroup upgraded shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and lifted their price target for the stock from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Wolfe Research initiated coverage on shares of Mettler-Toledo International in a research note on Friday, December 13th. They set a “peer perform” rating on the stock. Finally, Robert W. Baird lifted their price target on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a research note on Monday, February 10th. One analyst has rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, Mettler-Toledo International currently has an average rating of “Hold” and a consensus target price of $1,368.00.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.